Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-26-259599
Filing Date
2026-06-05
Accepted
2026-06-05 16:15:25
Documents
15
Effectiveness Date
2026-06-05

Document Format Files

Seq Description Document Type Size
1 S-8 okur-20260604.htm S-8 123197
2 EX-4.5 okur-ex4_5.htm EX-4.5 130216
3 EX-5.1 okur-ex5_1.htm EX-5.1 18027
4 EX-23.1 okur-ex23_1.htm EX-23.1 4458
5 EX-FILING FEES okur_exfilingfees.htm   iXBRL EX-FILING FEES 49326
6 GRAPHIC img201043379_0.jpg GRAPHIC 18643
  Complete submission text file 0001193125-26-259599.txt   478224

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT okur_exfilingfees_htm.xml XML 8130
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-296544 | Film No.: 261069268
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)